50 multinational pharmaceutical companies recorded only a 1.4% increase in sales last year

Korean branches of multinational pharmaceutical companies, which have entered to the Korean market, also recorded poor sales performance last year due to governmental regulations and economic depression in the pharmaceutical industry.

While the increase rate of their sales hit the lowest ever in the history, business and net profits were decreased compared to the last year, lowering profitabil...